Search results
Showing 1 to 6 of 6 results for baloxavir marboxil
Baloxavir marboxil for treating acute uncomplicated influenza (terminated appraisal) (TA732)
NICE is unable to make a recommendation on baloxavir marboxil (Xofluza) for treating acute uncomplicated influenza in people aged 12 and over. This is because Roche did not provide an evidence submission.
Show all sections
Sections for TA732
Baloxavir marboxil for influenza prophylaxis in people aged 12 and over [ID3793]
Awaiting development Reference number: GID-TA10684 Expected publication date: TBC
Baloxavir marboxil for treating influenza in people at high risk of complications [ID3794]
Awaiting development Reference number: GID-TA10683 Expected publication date: TBC
Baloxavir marboxil for treating influenza in babies under 1 year [ID6555]
In development Reference number: GID-TA11712 Expected publication date: TBC
In development Reference number: GID-TA11646 Expected publication date: TBC